(Q43265562)

17 November 2017

0 references

Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia (English)

1 reference

17 November 2017

1 reference

Prabhavathy Das

1

1 reference

17 November 2017

Abjal Pasha Shaik

series ordinal

2

1 reference

17 November 2017

Vamsee K Bammidi

series ordinal

3

1 reference

17 November 2017

publication date

1 August 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

50

1 reference

17 November 2017

issue

8

1 reference

17 November 2017

page(s)

1345-1351

1 reference

Prognostic factors in acute myelogenous leukemia

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Study of genetic polymorphism of xenobiotic enzymes in acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

Glutathione S-transferases (GSTT1 and GSTM1) genes polymorphisms and the treatment response and prognosis in Chinese patients with de novo acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903003236

10.1080/10428190903003236

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference